Drug regulator Drugs Controller General of India (DCGI) has approved Itolizumab, for restricted emergency use on Covid-19 patients with moderate to severe acute respiratory distress. Itolizumab is already in use to cure skin ailment psoriasis. Drug maker Biocon has been selling the medicine under brand Alzumab in India for psoriasis since 2013.
from Times of India https://ift.tt/3iSGhQl
via IFTTT
Saturday, July 11, 2020
Free Press Journal | World News
The Indian Express | World News
The Indian Express | Sports
Times of India | World News Headlines, Latest International News, World Breaking News
The Guardian | World News
Dash & Outdoor Cameras from Rexing
Search cheapest worldwide Flight/Hotel/Cruise/Car/Activities
Travel Insurance
0 comments:
Post a Comment